Jeffrey C. Gingrich, PhD, MBA – Principal

Dr. Gingrich has over 25 years experience in biotechnology/life sciences R&D. As a specialist in a variety of detection technologies, he has a broad knowledge of genomics and proteomics research systems (hardware, software, reagents, and applications). Dr. Gingrich was most recently at Bio-Rad Laboratories where he led the development and commercialization of a number of instrument systems and support reagents. The life science research platforms included laser scanning and CCD imagers, microarray scanners and spotters, microfluidic (Lab on a Chip) systems, multiplex immunoassay systems, as well as real time PCR instrument systems. His business development activities included early stage evaluation and market analysis on new instrument systems and applications for these systems. Prior to Bio-Rad, he was a scientist with the Human Genome Project at the Lawrence Berkeley and Lawrence Livermore National Labs, where he was instrumental in the development of new large insert cloning, chromosome mapping, high throughput screening, and automated DNA sequencing technologies which led to the first human genome sequence. His collaborations with researchers around the world also led to the identification of a number of disease associated genes, including the first identification and cloning of the breast cancer gene BRCAI. Prior to his work on the Genome Project, Dr. Gingrich studied the biophysical and genetic analysis of photosynthesis at Lawrence Berkeley National Laboratory and was an NIH Post Doctoral Fellow at the University of Colorado, Boulder where he collaborated with several of the leaders in the nascent fields of DNA synthesis and sequencing. Dr. Gingrich has published many scientific articles and book chapters as well as conference abstracts. He obtained both his BA in Bacteriology and a PhD in Microbiology from the University of California, Berkeley, and an MBA from Saint Mary’s College in Moraga, California.

< Back to Team